Communication with patients with Alzheimer`s Disease 4
0 SAR
Checkout
Overview
These videos provide guidance on how to properly communicate diagnosis for patients with Alzheimer`s disease.This Class for
- Physician
- Resident / Fellow
What I will learn?
- Increase disease awareness and diagnosis
Disclaimer
This content is approved by Eli Lilly and Company (“Lilly”). This content is intellectual property of Lilly and its reproduction needs Lilly's prior permission
(This information/content is intended to Health Care Providers only)
For adverse events and safety reporting: email: saudi_pharmacovigilance@lilly.com
24 /7 mobile: +966 567 868 843, Working hours Tel: +966 11 461 7800 , Ext: 1
For further information, please contact:
Eli Lilly and Company, Scientific Office P.O. Box 92120 Riyadh 11653, Kingdom of Saudi Arabia. Tel: +966 11 461 7800 Fax: +966 111 217 9900 email:
Saudi_Pharmacovigilance@lilly.com
PP-AD-SA-0152
Related Classes
- Communication with patients with Alzheimer`s Disease 3
- Communication with patients with Alzheimer`s Disease 6
- Communication with patients with Alzheimer`s Disease 5
- Communication with patients with Alzheimer`s Disease 2
- Communication with patients with Alzheimer`s Disease 1
- Barriers and benefits to a timely diagnosis
- Tracking the pathology of Alzheimer's disease
- State-of-the-art biomarker toolkit